what happened at the egm?, page-16

Cooko55 - In support of my assertion that the 2 appointed directors are not qualified according to the old board, here is a direct quote from the letter to shareholders dated 20 October 2011, signed by Stephen Jones and which also contains the threat by the board to resign en masse.

"Your Board considers that the proposed directors will not add value to the company and may indeed put at risk the considerable progress made by the company with pharmaceutical companies. The Board is most concerned about the proposed new directors having:
? No drug development experience
? Lack of connections with potential licensee pharmaceutical companies
? Absence of experience with a pharmaceutical company partner in bringing a drug to commercialisation
? No history in concluding licensing agreements in the pharmaceutical industry
? Lack of knowledge of the science underpinning XToll."

Do the 2 appointed directors meet any of these "qualifications"? Well, no.